Snoop Dogg-Led Investment Fund Casa Verde Capital Closes Nearly $100 Million Round
Cannabis investments are heating up yet again. This time, it’s good news for Casa Verde Capital, the fund run by Snoop Dogg (real name Calvin Broadus), Ted Chung, and Karan Wadhera. Casa Verde closed a nearly $95 million round, according to a Form D filed this week with the Securities & Exchange Commission.
This is the third successful fund for Casa Verde but by far the largest to date. The first was in 2015, with the group closing $25 million, while a second closed in 2018 with $45 million.
Casa Verde has amassed a portfolio over the last half-decade valued at roughly $200 million, according to TechCrunch. The investment fund has helped several prominent cannabis industry companies, including delivery behemoth Eaze as well as LeafLink, an online wholesale directory.
The successful round is yet another shining example of how the cannabis industry is bouncing back, despite a burst bubble in 2019 and the subsequent coronavirus pandemic. Analysts believe 2021 could be a banner year for the marijuana marketplace, especially after election outcomes demonstrating unilateral support for legalization in the United States.
Latest News
California Cannabis Brand, Rose, Teams Up with Kiva Sales and Service to Expand Product Line
LOS ANGELES-- Rose, California's cannabis brand, announced today an exclusive partnership with Kiva Sales and Service (KSS), a top sales and distribution platform that offers dispensaries a curated selection of the best brands in the ...
Australian Nurses Call for Medicinal Cannabis Education in Undergraduate Degrees
The group wants education about the endocannabinoid system included in undergraduate nursing degrees. Seven years ago, the Federal Parliament passed legislation to legalise medicinal cannabis in Australia. Since then, most cannabis medications have been classified ...
Psychedelic Firm Reunion Neuroscience Sues Mindset Pharma for Patent Infringement and Breach of Contract
LOS ANGELES-- Clinical research firm Reunion Neuroscience Inc. has filed a lawsuit against Mindset Pharma Inc. in federal court, alleging that the latter copied its psychedelic formula and presented it as its own invention while ...